Genetec Corporation
Q1 FY2027 Financial Summary (Japanese GAAP) (Consolidated)
In the first quarter of the fiscal year ending March 2027, net sales were 2,535 million yen, up 2.0% YoY, operating income was 20 million yen, down 24.0% YoY, ordinary income was 18 million yen, down 53.4% YoY, and net income attributable to owners of the parent was 4 million yen, down 80.7% YoY. The full-year earnings forecast remains unchanged. While collaboration with Moreason Japan shows improving profitability, overall profitability remains burdened by higher fixed costs and the transition to the new structure. A supplementary materials preparation is noted.
Key Figures
- Net sales: 2,535百万円 (YoY +2.0%)
- Operating income: 20百万円 (YoY △24.0%)
- Net income attributable to owners of the parent: 4百万円 (YoY △80.7%)
AI要約
Overview of Results
Under Mid-Term Management Plan 2026-2028, while expanding the System Solutions business, the Engineering Solutions business is recording a decline in revenue. Although cumulative net sales for Q1 increased, operating income, ordinary income, and net income were below the prior year. Profitability improvement from collaboration with Moreason Japan is ongoing, but overall fixed costs and transition to the new structure continue to impact results. A supplementary earnings materials preparation is noted.
Outlook and Key Points
No changes to the full-year guidance, but challenges include reducing low-margin engineering projects and achieving new KPIs. Through execution of the mid-term plan, the company intends to strengthen profitability of System Solutions and further elevate the added value of Engineering. As a notable post-event development, the company announced the full consolidation of Class Technology as a wholly owned subsidiary; future integration effects are to be watched.
Genetic
Company overview · Stock price · Financial data · All IR
